Vera Therapeutics (VERA) Cash from Operations (2020 - 2026)
Vera Therapeutics posted quarterly Cash from Operations of 106500000.0 for Q1 2026, down 95.75% year-on-year from 2506158737.02 in Q1 2025, and down 52.16% on a QoQ basis from 69994000.0 in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Cash from Operations data on file, last reported at 106500000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 95.75% year-over-year to 106500000.0; the trailing twelve-month figure through Mar 2026 stood at 293198000.0 (down 88.85% YoY), and the FY2025 full-year result was 241104000.0, down 79.02% from the prior year.
- Cash from Operations for Q1 2026 stood at 106500000.0, down from 69994000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8981000.0 in Q1 2022 and bottomed at 106500000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 26292000.0 (2023), against an average of 37768235.29.
- The widest annual swing landed in 2022, when Cash from Operations sank 235.89%; it then advanced 6.63% in 2023.
- A 5-year view of Cash from Operations shows it stood at 21162000.0 in 2022, then retreated by 18.82% to 25144000.0 in 2023, then slumped by 55.83% to 39182000.0 in 2024, then tumbled by 78.64% to 69994000.0 in 2025, then plunged by 52.16% to 106500000.0 in 2026.
- The last three Cash from Operations figures came in at 106500000.0 (Q1 2026), 69994000.0 (Q4 2025), and 61906000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -106.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.50 Mn |
| Mar 31, 2026 | -106.50 Mn |
| Dec 31, 2025 | -69.99 Mn |
| Dec 31, 2025 | -69.99 Mn |
| Sep 30, 2025 | -61.91 Mn |
| Sep 30, 2025 | -61.91 Mn |
| Jun 30, 2025 | -54.80 Mn |
| Jun 30, 2025 | -54.80 Mn |
| Mar 31, 2025 | -54.41 Mn |
| Mar 31, 2025 | -54.41 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Dec 31, 2024 | -39.18 Mn |
| Sep 30, 2024 | -36.89 Mn |
| Sep 30, 2024 | -36.89 Mn |
| Jun 30, 2024 | -24.78 Mn |
| Jun 30, 2024 | -24.78 Mn |
| Mar 31, 2024 | -33.83 Mn |
| Mar 31, 2024 | -33.83 Mn |
| Dec 31, 2023 | -25.14 Mn |
| Dec 31, 2023 | -25.14 Mn |
| Sep 30, 2023 | -22.97 Mn |
| Sep 30, 2023 | -22.97 Mn |
| Jun 30, 2023 | -17.77 Mn |
| Jun 30, 2023 | -17.77 Mn |
| Mar 31, 2023 | -26.29 Mn |
| Mar 31, 2023 | -26.29 Mn |
| Dec 31, 2022 | -21.16 Mn |
| Dec 31, 2022 | -21.16 Mn |
| Sep 30, 2022 | -18.42 Mn |
| Sep 30, 2022 | -18.42 Mn |
| Jun 30, 2022 | -19.03 Mn |
| Jun 30, 2022 | -19.03 Mn |
| Mar 31, 2022 | -8.98 Mn |
| Mar 31, 2022 | -8.98 Mn |
| Dec 31, 2021 | -6.44 Mn |
| Dec 31, 2021 | -6.44 Mn |
| Sep 30, 2021 | -5.48 Mn |
| Sep 30, 2021 | -5.48 Mn |
| Jun 30, 2021 | -7.67 Mn |
| Jun 30, 2021 | -7.67 Mn |
| Mar 31, 2021 | -4.12 Mn |
| Mar 31, 2021 | -4.12 Mn |
| Dec 31, 2020 | -27.38 Mn |
| Dec 31, 2020 | -27.38 Mn |
| Sep 30, 2020 | -2.45 Mn |
| Sep 30, 2020 | -2.45 Mn |
| Jun 30, 2020 | -2.68 Mn |
| Jun 30, 2020 | -2.68 Mn |
| Mar 31, 2020 | -2.31 Mn |
| Mar 31, 2020 | -2.31 Mn |